Phenazopyridine

CHEMBL1242 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
213.2 g/mol
LogP
1.9
Phase
4

A urinary pain reliever that works directly in the bladder and urinary tract to reduce the burning, stinging, and discomfort caused by urinary tract infections or other irritation. It turns the urine a distinctive orange or red color, which is a harmless side effect.

분자량

213.2400 g/mol

LogP

1.90

TPSA

89.70 Ų

리핀스키 5의 법칙

통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1ccc(/N=N/c2ccccc2)c(N)n1

InChI

InChI=1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14)/b16-15+

Molecular Formula

C11H11N5

HBD / HBA

2 / 5

회전 가능 결합

2

무거운 원자

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A urinary pain reliever that works directly in the bladder and urinary tract to reduce the burning, stinging, and discomfort caused by urinary tract infections or other irritation. It turns the urine a distinctive orange or red color, which is a harmless side effect.

Yes, Phenazopyridine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1242. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4756. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.